Cargando…
MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405287/ https://www.ncbi.nlm.nih.gov/pubmed/29733684 http://dx.doi.org/10.1080/13506129.2018.1465406 |
_version_ | 1783401049856409600 |
---|---|
author | Illman, Jeffery E. Arunachalam, Shivaram P. Arani, Arvin Chang, Ian Cheng-Yi Glockner, James F. Dispenzieri, Angela Grogan, Martha Araoz, Philip A. |
author_facet | Illman, Jeffery E. Arunachalam, Shivaram P. Arani, Arvin Chang, Ian Cheng-Yi Glockner, James F. Dispenzieri, Angela Grogan, Martha Araoz, Philip A. |
author_sort | Illman, Jeffery E. |
collection | PubMed |
description | OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-cause mortality in AL amyloidosis. MATERIALS AND METHODS: Seventy-six patients with newly diagnosed AL amyloidosis underwent cardiac MRI. 75 had images suitable for MRI FT strain analysis. MRI delayed enhancement, morphologic and functional evaluation, cardiac biomarker staging and transthoracic echocardiography were also performed. Subjects’ charts were reviewed for all-cause mortality. Cox proportional hazards analysis was used to evaluate survival in univariate and multivariate analysis. RESULTS: There were 52 deaths. Median follow-up of surviving patients was 1.7 years. In univariate analysis, global radial (Hazard Ratio (HR)=0.95, p<.01), circumferential (HR=1.09, p< .01) and longitudinal (HR=1.08, p< .01) strain were associated with all-cause mortality. In separate multivariate models, radial (HR=0.96, p=.02), circumferential (HR=1.09, p=.03) and longitudinal strain (HR=1.07, p=.04) remained prognostic when combined with presence of biomarker stage 3. CONCLUSIONS: MRI FT strain is associated with all-cause mortality in patients with AL amyloidosis. |
format | Online Article Text |
id | pubmed-6405287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-64052872019-03-07 MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis Illman, Jeffery E. Arunachalam, Shivaram P. Arani, Arvin Chang, Ian Cheng-Yi Glockner, James F. Dispenzieri, Angela Grogan, Martha Araoz, Philip A. Amyloid Article OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-cause mortality in AL amyloidosis. MATERIALS AND METHODS: Seventy-six patients with newly diagnosed AL amyloidosis underwent cardiac MRI. 75 had images suitable for MRI FT strain analysis. MRI delayed enhancement, morphologic and functional evaluation, cardiac biomarker staging and transthoracic echocardiography were also performed. Subjects’ charts were reviewed for all-cause mortality. Cox proportional hazards analysis was used to evaluate survival in univariate and multivariate analysis. RESULTS: There were 52 deaths. Median follow-up of surviving patients was 1.7 years. In univariate analysis, global radial (Hazard Ratio (HR)=0.95, p<.01), circumferential (HR=1.09, p< .01) and longitudinal (HR=1.08, p< .01) strain were associated with all-cause mortality. In separate multivariate models, radial (HR=0.96, p=.02), circumferential (HR=1.09, p=.03) and longitudinal strain (HR=1.07, p=.04) remained prognostic when combined with presence of biomarker stage 3. CONCLUSIONS: MRI FT strain is associated with all-cause mortality in patients with AL amyloidosis. 2018-05-07 2018-06 /pmc/articles/PMC6405287/ /pubmed/29733684 http://dx.doi.org/10.1080/13506129.2018.1465406 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Article Illman, Jeffery E. Arunachalam, Shivaram P. Arani, Arvin Chang, Ian Cheng-Yi Glockner, James F. Dispenzieri, Angela Grogan, Martha Araoz, Philip A. MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title_full | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title_fullStr | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title_full_unstemmed | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title_short | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
title_sort | mri feature tracking strain is prognostic for all-cause mortality in al amyloidosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405287/ https://www.ncbi.nlm.nih.gov/pubmed/29733684 http://dx.doi.org/10.1080/13506129.2018.1465406 |
work_keys_str_mv | AT illmanjefferye mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT arunachalamshivaramp mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT araniarvin mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT changianchengyi mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT glocknerjamesf mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT dispenzieriangela mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT groganmartha mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis AT araozphilipa mrifeaturetrackingstrainisprognosticforallcausemortalityinalamyloidosis |